Study highlights lack of data on transgender leukemia patientsApril 19, 2019AMLLeukemia, Myelodysplasia, Transplantation
ALF 2019 showcases evolving treatment of AMLApril 19, 2019AMLLeukemia, Myelodysplasia, TransplantationTransplantation
Back to the drawing board for MPN comboApril 18, 2019Leukemia, Myelodysplasia, TransplantationCythemiasAML
Creating CAR T-cell therapies for T-cell malignanciesApril 16, 2019ALLLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Bendamustine/rituximab combo proves viable for comorbid CLLApril 10, 2019Leukemia, Myelodysplasia, Transplantation
Whole-genome sequencing demonstrates clinical relevanceApril 4, 2019AMLALLLeukemia, Myelodysplasia, Transplantation
Ibrutinib sustained responses in refractory CLL in long-term follow-upMarch 27, 2019Leukemia, Myelodysplasia, Transplantation
MRD status at transplant predicts outcomes in ALL patientsMarch 14, 2019TransplantationALLLeukemia, Myelodysplasia, Transplantation
Secondary AML in first remission predicts outcomesMarch 14, 2019TransplantationLeukemia, Myelodysplasia, TransplantationAML
Haplo-HSCT bests chemotherapy for MRD-positive adult ALLMarch 13, 2019TransplantationALLLeukemia, Myelodysplasia, Transplantation
Anti-CD45 conditioning looks safe, feasible in relapsed AMLMarch 13, 2019TransplantationAMLLeukemia, Myelodysplasia, Transplantation
HDACi, HMA combo improves survival for older AML patientsMarch 13, 2019AMLLeukemia, Myelodysplasia, Transplantation
Guadecitabine may be option for certain MDS/AML patientsMarch 12, 2019AMLLeukemia, Myelodysplasia, Transplantation
Post-HCT azithromycin doesn’t increase relapse risk, study suggestsMarch 3, 2019Leukemia, Myelodysplasia, TransplantationTransplantation
CLL, GVHD may raise risk for skin cancer after allo-HCTFebruary 28, 2019TransplantationLeukemia, Myelodysplasia, Transplantation
